Analysts Point To Emergent Biosolutions Inc (NYSE: EBS) Growth In The Future

After Hours

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.

Stocks Info

As a NYSE listed company, EBS falls under the Healthcare sector while operating within the Drug Manufacturers – Specialty & Generic industry segment. The current market capitalization of Emergent Biosolutions Inc is $469.00M. A total of 1.04 million shares were traded on the day, compared to an average of 1.59M shares.

In the most recent transaction, DeGolyer Donald W sold 25,000 shares of EBS for 10.91 per share on Nov 12 ’24. After the transaction, the Director now owns 111,100 company shares. In a previous transaction on Nov 11 ’24, White Marvin L sold 14,287 shares at 11.97 per share. EBS shares that Director owns now total 54,092.

Among the insiders who bought shares, DeGolyer Donald W acquired of 25,000 shares on Nov 12 ’24 at a per-share price of $11.77. In another insider transaction, White Marvin L bought 14,287 shares at $11.77 per share on Nov 11 ’24.

In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, EBS has a high of $15.10 and a low of $1.42.

Balance Sheet Annually/Quarterly

The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. EBS’s latest balance sheet shows that the firm has $576.10M in Cash & Short Term Investments as of fiscal 2021. There were $841.00M in debt and $374.00M in liabilities at the time. Its Book Value Per Share was $9.40, while its Total Shareholder’s Equity was $1.61B.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for EBS is Buy with a score of 3.67.

Most Popular

Related Posts